These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23985406)

  • 21. Incidence and clinical significance of late right heart failure during continuous-flow left ventricular assist device support.
    Takeda K; Takayama H; Colombo PC; Yuzefpolskaya M; Fukuhara S; Han J; Kurlansky P; Mancini DM; Naka Y
    J Heart Lung Transplant; 2015 Aug; 34(8):1024-32. PubMed ID: 25935438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular assist device-related infection: treatment and outcome.
    Simon D; Fischer S; Grossman A; Downer C; Hota B; Heroux A; Trenholme G
    Clin Infect Dis; 2005 Apr; 40(8):1108-15. PubMed ID: 15791509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous-flow left ventricular assist device and the right ventricle.
    Puhlman M
    AACN Adv Crit Care; 2012; 23(1):86-90. PubMed ID: 22290094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation.
    Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Zuckermann AO; Wieselthaler GM
    J Heart Lung Transplant; 2009 Apr; 28(4):367-72. PubMed ID: 19332264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support.
    Petrucci RJ; Rogers JG; Blue L; Gallagher C; Russell SD; Dordunoo D; Jaski BE; Chillcott S; Sun B; Yanssens TL; Tatooles A; Koundakjian L; Farrar DJ; Slaughter MS
    J Heart Lung Transplant; 2012 Jan; 31(1):27-36. PubMed ID: 22153550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation.
    Raasch H; Jensen BC; Chang PP; Mounsey JP; Gehi AK; Chung EH; Sheridan BC; Bowen A; Katz JN
    Am Heart J; 2012 Sep; 164(3):373-8. PubMed ID: 22980304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Midterm outcome of implantable left ventricular assist devices as a bridge to transplantation: Single-center experience in Japan.
    Kimura M; Kinoshita O; Nawata K; Nishimura T; Hatano M; Imamura T; Endo M; Kagami Y; Kubo H; Kashiwa K; Kinugawa K; Kyo S; Komuro I; Ono M
    J Cardiol; 2015 May; 65(5):383-9. PubMed ID: 25034705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. European results with a continuous-flow ventricular assist device for advanced heart-failure patients.
    Lahpor J; Khaghani A; Hetzer R; Pavie A; Friedrich I; Sander K; Strüber M
    Eur J Cardiothorac Surg; 2010 Feb; 37(2):357-61. PubMed ID: 19616963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database.
    Healy AH; Baird BC; Drakos SG; Stehlik J; Selzman CH
    Ann Thorac Surg; 2013 Mar; 95(3):870-5. PubMed ID: 23218024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices.
    Argenziano M; Catanese KA; Moazami N; Gardocki MT; Weinberg AD; Clavenna MW; Rose EA; Scully BE; Levin HR; Oz MC
    J Heart Lung Transplant; 1997 Aug; 16(8):822-31. PubMed ID: 9286774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
    Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
    Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphologic changes in the aortic wall media after support with a continuous-flow left ventricular assist device.
    Segura AM; Gregoric I; Radovancevic R; Demirozu ZT; Buja LM; Frazier OH
    J Heart Lung Transplant; 2013 Nov; 32(11):1096-100. PubMed ID: 23968812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure.
    Slaughter MS; Pagani FD; Rogers JG; Miller LW; Sun B; Russell SD; Starling RC; Chen L; Boyle AJ; Chillcott S; Adamson RM; Blood MS; Camacho MT; Idrissi KA; Petty M; Sobieski M; Wright S; Myers TJ; Farrar DJ;
    J Heart Lung Transplant; 2010 Apr; 29(4 Suppl):S1-39. PubMed ID: 20181499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience with right ventricular assist devices for perioperative right-sided circulatory failure.
    Chen JM; Levin HR; Rose EA; Addonizio LJ; Landry DW; Sistino JJ; Michler RE; Oz MC
    Ann Thorac Surg; 1996 Jan; 61(1):305-10; discussion 311-3. PubMed ID: 8561595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of APACHE II scores to select candidates for left ventricular assist device placement. Acute Physiology and Chronic Health Evaluation.
    Gracin N; Johnson MR; Spokas D; Allen J; Bartlett L; Piccione W; Parrillo JE; Costanzo MR; Calvin JE
    J Heart Lung Transplant; 1998 Oct; 17(10):1017-23. PubMed ID: 9811411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality.
    Morgan JA; John R; Lee BJ; Oz MC; Naka Y
    Ann Thorac Surg; 2004 Mar; 77(3):859-63. PubMed ID: 14992887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation.
    Nativi JN; Drakos SG; Kucheryavaya AY; Edwards LB; Selzman CH; Taylor DO; Hertz MI; Kfoury AG; Stehlik J
    J Heart Lung Transplant; 2011 Aug; 30(8):854-61. PubMed ID: 21571550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.